Global
Public-private partnerships (PPPs) are playing a pivotal role in strengthening Southeast Asia’s healthcare systems by expanding access, enhancing infrastructure, and fostering innovation amid growing demand and resource constraints.
In a significant milestone for corporate sustainability, DKSH Thailand has been recognized as a Climate Action Leader 2025 by the Agricultural and Food Marketing Association for Asia and the Pacific (AFMA). This honor underscores DKSH Thailand’s deep commitment to driving sustainable business practices that benefit both people and the planet.
The Asia-Pacific (APAC) region, home to 60% of the global population, is emerging as a key market for global medical device companies. This shift is underscored by the potential of the APAC region, which encompasses a diverse array of cultures, languages, and socioeconomic backgrounds, and a healthcare market that has already surpassed Europe to become the second-largest market globally, right behind the United States.
Thailand’s healthcare system is rapidly evolving, driven by the government’s Thailand 4.0 vision and the Ministry of Public Health’s Digital Health Strategy (2021–2025). Health technology (Healthtech) is now a key driver in enhancing patient care, hospital efficiency, and accessibility.
The proliferation of health tech innovations is accelerating exponentially. In 2023, the global digital health market was estimated at USD 240.9 billion and projected to grow at a compound annual growth (CAGR) of 21.9% from 2024 to 2030. This growth has been further accelerated by the COVID-19 pandemic, especially in evolving markets in Asia Pacific.
Global medical tourism has experienced significant growth in the past few decades. This is fueled by the increasing accessibility of affordable travel as well as improved access to high-quality care in emerging markets as they provide a more attractive choice than developed nations.
Singapore’s status as a leading medical tourism destination is threatened as international patients opt for cheaper alternatives. Rising medical costs and intensified competition from regional players like Thailand and Malaysia also drive foreign patients away from Singapore.
Southeast Asia stands at a pivotal moment in healthcare development. While the region represents 8.5% of the world’s population, it accounts for only 1.4% of global healthcare expenditure, a disparity that signals both challenges and unprecedented opportunities.
Thailand is experiencing a significant demographic shift. By 2031, over 20% of its population will be aged 65 or older, making it a super-aging society. This rapid shift presents challenges for the healthcare system but also opens doors for innovation and collaboration.
DKSH joined hands with a leading derma-cosmetic brand to provide better access to quality consumer health products.
Alzheimer’s disease, and other forms of dementia, are progressive neurological disorders that lead to memory loss, cognitive decline, and the eventual inability to carry out simple tasks. Currently, more than 55 million people worldwide are living with dementia, with nearly 10 million new cases diagnosed each year with Alzheimer’s contributing up to 70% of these cases, as reported by the World Health Organization (WHO).
Ensuring patient safety in a rapidly evolving healthcare landscape is crucial as we shift focus from longevity to living healthier, more vital lives through technological innovation and personalized care.
Packaging plays a crucial role in the global supply chain, safeguarding products and ensuring they reach consumers in optimal condition. This is especially true in cold chain logistics, where temperature-sensitive products like pharmaceuticals and perishable goods require precise thermal management.
DKSH Thailand leverages innovative healthcare technology and adopts a patient-centric approach to overcome challenges in medical device delivery, ensuring timely and efficient supply chain management that benefits patients.
The medical devices market in Vietnam is set for growth. Ten years ago, it was valued at USD 645 million, with 92% of devices imported and limited domestic production. By 2027, the market is projected to reach USD 2.4 billion, making it a promising sector for foreign investment due to economic growth and rising demand for quality medical care and equipment.
The partnership between DKSH Thailand and Thammasat University Hospital (TUH) is breathing new life into healthcare delivery by offering convenient homecare services that put patients first. This collaboration not only enhances patient well-being but also tackles the challenge of reducing hospital overcrowding.
In an exclusive interview with Yakup Pharmaceutical Newspaper, Bijay Singh, Head Business Unit Healthcare at DKSH, discusses the Group’s strategies for the Korean market. DKSH recently launched the Atacand brand in South Korea.
Billions of people still lack access to essential health services. Despite significant progress in healthcare policy reforms across Asia, many people still lack access to essential health services, and governments are increasingly turning to the private sector to bridge these gaps.
In an exclusive interview with BioPharma APAC, Reuben Ong, Vice President of Business Unit Healthcare at DKSH Singapore, discusses strategies to overcome regulatory hurdles, vaccine hesitancy, and logistical challenges to ensure timely access to vaccines across the Asia Pacific region.
A technology-powered vision of our healthcare future is now a reality. Our smartwatches and fitness trackers continuously monitor our physical activities and sleep patterns. On our phones, a plethora of digital health apps takes the data from these trackers to monitor trends and detect changes.
Embarking on a transformative journey, the Faculty of Medicine at Siriraj Hospital, in collaboration with DKSH Healthcare Thailand, redefines healthcare finance. Pioneering digital payment solutions, DKSH emerges as the catalyst, propelling the faculty towards unparalleled transparency, security, and efficiency.
ติดต่อเราเพื่อค้นหาโอกาสใหม่ ๆ
ติดต่อเรา